Writing for Wired, Keith Gillogly spotlights how MIT researchers have devised a new technique that could lead to the development of lab-grown wood and other biomaterials. “The hope is that, if this becomes a developed process for producing plant materials, you could alleviate some of [the] pressures on our agricultural lands. And with those reduced pressures, hopefully we can allow more spaces to remain wild and more forests to remain in place,” says graduate student Ashley Beckwith,
Popular Mechanics reporter Kyro Mitchell explores how MIT researchers have created a biodegradable medical patch that could be used to repair internal injuries. Mitchell notes that the patch “can be easily wrapped around robotic tools like a balloon catheter and a surgical stapler and then be inserted into the patient.”
Mashable reporter Kellen Beck spotlights how MIT researchers have developed a new medical patch that could be used to repair tears in organs and tissues.” Because internal surgeries involve small, specialized tools, the patch was created to fold around these tools and make insertion and use in tight spaces simpler. The patch resists contamination and biodegrades over time,” writes Beck.
Fast Company reporter Kristin Toussaint writes about how MIT researchers have developed a new technique for growing wood-like plant tissues in the lab. The work, they say, is still in its very early stages, but provides a starting point to a new way of producing biomaterials. “It’s a process that eventually could help accelerate our shift away from plastics and other materials that end up in landfill toward materials that can biodegrade,” writes Toussaint.
TechCrunch reporter Darrell Etherington writes that MIT researchers have developed a new method for growing plant tissues in a lab. “Potential applications of lab-grown plant material are significant,” writes Etherington, “and include possibilities in both agriculture and in construction materials.”
Boston Globe reporter Jon Chesto writes that MIT, Harvard, several research hospitals and life-sciences companies have selected a site for a new biologics manufacturing and innovation center. The project is aimed at expediting “discoveries for biotech treatments in university labs by allowing researchers to bypass the long waits that are common at contract manufacturers,” writesChesto.
Boston Globe columnist Shirley Leung spotlights how the development of the Moderna Covid-19 vaccine demonstrates the success of the Massachusetts life sciences sector. “For more than half a century, the Massachusetts Institute of Technology has been the epicenter of that curiosity, with a focus on molecular biology — initially to find a cure for cancer,” writes Leung. “There have been Nobel laureates collaborating on cancer, genetics, and immunology, along with future laureates making discoveries in how RNA, a molecule that is as fundamental as DNA to cell function, can be used in medicine.”
European Pharmaceutical Review reporter Hannah Balfour writes that researchers from the Singapore-MIT Alliance for Research and Technology have developed a new dissolvable gelatin microcarrier that can help enhance cell production. “Innovations in microcarriers will aid in the scalability of certain cell types such as mesenchymal stromal cells for cell-based therapy, including for regenerative medicine applications,” says Associate Provost Krystyn Van Vliet.
STAT reporter Kate Sheridan spotlights the work of Kartik Ramamoorthi PhD ’14 and his gene therapy company Encoded. Sheridan explains that Encoded’s first gene therapy will “target Dravet syndrome — a rare condition that can cause seizures, cognitive deficits, and mobility problems.”
Tech Explorist reporter Amit Malewar writes that researchers from Singapore-MIT Alliance for Research and Technology (SMART) have “demonstrated a new way to manufacture human red blood cells (RBCs) that cuts the culture time by half compared to existing methods.”
A study by researchers from MIT’s Singapore-MIT Alliance for Research and Technology (SMART) finds antibiotic resistance in some types of bacteria may be reversed using hydrogen sulphide, reports Melanie Sison for SciDevNet. “This is a very exciting discovery because we are the first to show that H2S can, in fact, improve sensitivity to antibiotics and even reverse antibiotic resistance in bacteria that do not naturally produce the agent,” says Wilfried Moreira, a principal investigator at SMART.
Researchers from the Singapore-MIT Alliance for Research and Technology have “discovered a way to increase antimicrobial sensitivity in bacteria by exposing them to hydrogen sulphide (H2S),” reports Health Europa.
Researchers from MIT and Harvard have developed a new biosensitive ink “that indicates one’s health condition by changing its color,” writes Seung Jae Park for The Los Angeles Times. “With the subtle embellishment of the ink with tattoo artistry, the team aims to overcome the shortcomings of the current biomedical monitoring devices.”
MIT researchers have developed a skin patch that could be used to fight melanoma, reports Berkeley Lovelace Jr. for CNBC. “Our patch technology could be used to deliver vaccines to combat different infectious diseases,” explains Prof. Paula Hammond. “But we are excited by the possibility that the patch is another tool in the oncologists’ arsenal against cancer, specifically melanoma.”
STAT reporter Kate Sheridan spotlights MIT startup Lyra Therapeutics, which is developing a long-acting treatment for chronic rhinosinusitis.